Ubicom Holdings. Inc. · TSE:3937
Ubicom — Q1 2022 Earnings Presentation
28 slides from Ubicom's earnings presentation, Aug 10, 2022
Slide 1: Presentation Materials for FY2022 Q1
FY2022 Q1 Consolidated Business Results Presentation Materials for FY2022 Q1 Ubicom Holdings, Inc. TSE Prime: 3937 August 10, 2022 Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the
Slide 2: FY2022 Q1 Highlights
FY2022 Q1 Highlights In addition to the establishment of highly profitable model, the investment from the second half of the previous fiscal year exerted effects, and we invested in recruitment of new graduates securing the growth of sales and profit. Profit hit a record high for the first quarter.
Slide 3: FY2022 Q1 (P/L)
FY2022 Q1 (P/L) To meet the strong demand for development and solutions, which became full-blown in the second half of the previous fiscal year, we enhanced strategic investment for cutting-edge personnel and recruitment of new graduates. The investment turned out to be effective and operating incom
Slide 4: Situation of investment in human resources, and measure on the effects of exchange rates
FY2022 Q1 Situation of investment in human resources, and measure on the effects of exchange rates Situation of investment in human resources, including recruitment Continued the investment in human resources. In the Philippines, where our foothold for development is located, we started active rec
Slide 5: FY2022 Q1 Overview of each segment: Global business
FY2022 Q1 Overview of each segment: Global business Secured a significant year on year growth trend in sales and profit without fail FY2021 FY2022 Global Business Year-on- Q1 Q1 Year (unit: million yen) Amount % to sales Amount % to sales Net Sales 750 100.0% 942 100.0% 125.6% Operating Income 102 1
Slide 6: Global Business: External environment and business strategy
Global Business: External environment and business strategy ■Evolution of our global business strategy Offshore 2.5 2.0 Improvement of the advanced personnel model 1.0 Expansion of the Skill development (in the AI field, etc.) Endeavor to enter the global market domestic market Establishment of the
Slide 7: Global Business: Advancement of Business Model
Global Business: Advancement of Business Model Generate pillar clients and high profitability through flexible offshore/onsite development Definition of pillar clients: Constant clients that are market leaders in each field with sales scale of several 100 million yen Establishment of Offshore (our d
Slide 8: Global Business: Business strategy
Global Business: Business strategy 1 Expecting the growth of global demand for IT personnel, mainly advanced AI personnel, we have been shifting to the high unit price model from this term. Measure ② Enhancement of advanced personnel Measure ① Application of Reinforcement of advanced engineers mainl
Slide 9: Global Business: Change and outlook of sales composition by strategic field
Global Business: Change and outlook of sales composition by strategic field We aim to expand the AI-related business by developing cutting-edge personnel. Since the outbreak of the coronavirus pandemic, the PC area has expanded steeply, due to the demand caused by the reform of workstyles, etc.
Slide 10: Global Business: Business strategy
Global Business: Business strategy 2 Promote business strategies targeted at the global market ■Concrete examples of FY2022 Go Global Strategy ① Promotion of global M&A ② Business alliances with global investees *The technological alliances with cutting-edge personnel and project managers of investe
Slide 11: Global Business: Enhancement of financial strategy
Global Business: Enhancement of financial strategy Diversification of the portfolio of currencies for sales to cope with the risk of exchange rates Through the organizational reform on July 1, 2022, the financial function was transferred from the accounting department to the corporate planning divis
Slide 12: FY2022 Q1 Overview of each segment: Medical business
FY2022 Q1 Overview of each segment: Medical business Maintained a high profitability and steady growth trend in profit FY2021 FY2022 Medical Business Year-on- Q1 Q1 Year (unit: million yen) Amount % to sales Amount % to sales Net Sales 367 100.0% 370 100.0% 101.0% Operating Income 191 52.2% 220 59.6
Slide 13: Medical Business: Advancement of Business Model
Medical Business: Advancement of Business Model Expansion of highly profitable foundation with the subscription model Trend of Medical Business Performance Sales Composition Trend of Medical Business (unit: million yen) *recurring ratio: continuous sales ratio © Ubicom Holdings, Inc. 13
Slide 14: Medical Business: External environment and business strategy
Medical Business: External environment and business strategy ■External environment surrounding the medical business: DX of DX of Reform of Improvement in administration workstyles of quality, safety, and healthcare accessibility (Mynaportal, etc.) medical doctors of healthcare ■Medical business stra
Slide 15: Medical Business: Improvement of solutions for reforming the workstyles of medical doctors
Medical Business: Improvement of solutions for reforming the workstyles of medical doctors At the International Modern Hospital Show 2022 in July 2022, we announced a next-generation solution for helping reform the workstyles of medical doctors, and started receiving advance orders. (New) (Provision
Slide 16: Medical Business: Effects of Mainstay Solutions
Medical Business: Effects of Mainstay Solutions ■Effects of Mighty Checker (MC) for Medical Affairs *1 (1) Reduction of operation time (2) Cost reduction and profit improvement Conventional medical claims inspection Inspection (Visual) of medical claims after introducing MC Inspection cost 100% Redu
Slide 17: Advancement of Insurance Knowledge Platform
Advancement of Insurance Knowledge Platform ■Progress of opportunities under negotiation ・Negotiations are underway with a total of 7 out of approx. 50 companies in the life insurance market ➡out of which, 3 companies are in the process of PoC verification for installation in FY2022 ➡2 semi-major co
Slide 18: Medical Domain: Growth Potential of each Solution
Medical Domain: Growth Potential of each Solution To promote further improvement of average spending per customer and recurring revenue earning capability through up-selling, cross-selling, and direct sales New Medical Platform Insurance Knowledge Platform SonaM Mighty QUBE + New MQ GP margin of Mig
Slide 19: Target Market Size for Medical Platforms
Target Market Size for Medical Platforms We aim to become the No. 1 platform in the niche medical field by leveraging our position as the market leader in DX solutions focused on medical institutions. New (domestic and overseas) Insurance Strategic Medical companies Markets institutions Insurance Kn
Slide 20: Medical Platform Utilization Strategy (Medium/Long-term Vision)
Medical Platform Utilization Strategy (Medium/Long-term Vision) To create more new markets through strategies to enclose the user community (potential market size: 300 billion yen*) *surveyed by our company ・Conversion of sales staff to consultants New market ・Medical engineer training Creation ・Str
Slide 21: Promotion of M&A strategy based on the results of acquisition of subsidiaries
Promotion of M&A strategy based on the results of acquisition of subsidiaries We aim to actualize new M&A that would contribute to our platformer strategy, by utilizing the know-how of post-merger integration (PMI) for medical business. ■Successful cases of M&A: Variation in results of medical busin
Slide 22: FY2022 Priority measures
FY2022 Priority measures While paying attention to the profit balance, we will take measures for fortifying the base for the second growth phase. 1. To enrich expert resources that would contribute to “Go Global Strategy” 2. To enhance the recruitment and training of Filipino engineers 3. To beef up
Slide 23: ESG: Towards Sustainable Development of Business, Society & Customer
ESG: Towards Sustainable Development of Business, Society & Customer ■Global Business ・DX Support (Business process reforms for clients through advanced technology support such as AI/Analytics/Automation/Cloud) ・Improvement of Japan’s global competitiveness through globalization support for domestic
Slide 24: Promotion of the group business based on social meanings
Promotion of the group business based on social meanings Entire group Medical business Resilient management, Provision of solutions that are beneficial personnel development strategy, to all parties as they contribute to the business synergy, and pursuit of reform of doctors’ workstyles, the signifi
Slide 25: Promotion of the Leverage Strategy (the 2nd Growth Phase)
Promotion of the Leverage Strategy (the 2nd Growth Phase) To maximize the synergy between the existing business and M&A, and promote the development of new recurring-revenue/SaaS model ・Medical field Themes of the ・Pillar clients: + 20 companies ・Global market ×M&A second growth phase ・Sustainabilit
Slide 26: Company Overview
Company Overview ■Company name: Ubicom Holdings, Inc. (TSE Prime: 3937) ■Strategic industry: Medical, Financial/Public, Automotive, Manufacturing/Robotics, etc. ■Our Business: Global Business Dedicated in solving IT resource shortage in Japan and promoting DX (Digital Transformation), through provid
Slide 27: Cautionary Note on Forward Looking Statements
Cautionary Note on Forward Looking Statements This material may contain forward looking statements and forecasts regarding the future outlook at the time of publication. They are subject to risks and uncertainties including, but not limited to, domestic and international economic conditions such
Slide 28: © Ubicom Holdings, Inc.
© Ubicom Holdings, Inc.